Company news

Conexeu Sciences Inc. news

Latest news releases, newest first.

View company

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

October 15, 2026

Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission

October 6, 2026

Conexeu Sciences Sets September and October 2026 Conference Schedule

September 1, 2026

Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration

August 11, 2026

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

July 13, 2026

Initial Statement of Beneficial Ownership (Form 3)

June 29, 2026

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

June 25, 2026

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

June 15, 2026

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

June 7, 2026

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

June 3, 2026

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 26, 2026

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

May 21, 2026

Decks